Additionally, the enhanced tumor-killing effect of CD8+ T cells under Nat10-KO conditions was abrogated by rDkk2 supplementation (Figure 6, G and H, and Supplemental Figure 7L). This evidence concerns the gene NAT10 and neoplasm.